March 22, 2022

The Future of Melanoma Research

Professor David Fisher, chairman of the Department of Dermatology and director of the Melanoma Program at Massachusetts General Hospital (@massgenbrigham) is our guest on episode 138 of the Futurized podcast (@Futurized2). Futurized host Trond Arne Undhe...

Show Notes
Guest Profile

In this conversation, they talk about the evolution of melanoma research and the advances made in recent years.

Trond's takeaway:

Melanoma is still a fear-inducing disease which has drastic consequences for the patients who contract it. On the other hand, the medical community has made significant advances against it in recent years, but it has taken time, a lot of attempts, and the battle is far from over. Immunotherapy has proven to be a game changer. But will all patients get this type of therapy in time and who will bear the costs?

Thanks for listening. If you liked the show, subscribe at Futurized.org or in your preferred podcast player, and rate us with five stars.

If you like this topic, you may enjoy other episodes of Futurized, such as episode 149, Melanoma Awareness, episode 147, Health Tech Reboot, or episode 88, The Future of Virtual Care. Hopefully, you'll find something awesome in these or other episodes. If so, do let us know by messaging us, we would love to share your thoughts with other listeners.

Futurized is created in association with Yegii, the insight network. Yegii lets clients create multidisciplinary dream teams consisting of a subject matter experts, academics, consultants, data scientists, and generalists as team leaders. Yegii's services include speeches, briefings, seminars, reports and ongoing monitoring. You can find Yegii at Yegii.org.

Please share this show with those you care about. To find us on social media is easy, we are Futurized on LinkedIn and YouTube and Futurized2 on Instagram and Twitter:

Instagram: https://www.instagram.com/futurized2/
Twitter (@Futurized2): https://twitter.com/Futurized2
Facebook: https://www.facebook.com/Futurized-102998138625787
LinkedIn: https://www.linkedin.com/company/futurized
YouTube: https://www.youtube.com/Futurized
Podcast RSS: https://feed.podbean.com/www.futurized.co/feed.xml

See you next time. Futurized—conversations that matter.

David Fisher

Professor

Dr. David Fisher is the chairman of the Department of Dermatology and director of the Melanoma Program and the Cutaneous Biology Research Center at Massachusetts General Hospital at Harvard Medical School. He is also the Edward Wigglesworth Professor of Dermatology at Harvard Medical School.

Dr. Fisher conducted postdoctoral research with Nobel Laureate Phillip Sharp at Massachusetts Institute of Technology. He earned his PhD from Rockefeller University with Drs. Henry Kunkel and Gunter Blobel, and his doctor of medicine degree at Cornell University. Dr. Fisher carried out his residency training in Internal Medicine at Massachusetts General Hospital Cancer Center as well as clinical fellowships in both adult and pediatric oncology at Dana-Farber Cancer Institute and Boston Children’s Hospital. He is also a graduate of the Curtis Institute of Music (cello) and Swarthmore College, where he earned a degree in Chemistry and Biology.